PMA supplement
P050051 S044: ARCHITECT AUSAB (LN 1L82)
FDA PMA supplement · 30-Day Notice · Abbott Laboratories, Inc.
Key facts
| Original PMA | P050051 |
|---|---|
| Supplement number | S044 |
| Supplement type | 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | ARCHITECT AUSAB (LN 1L82) |
| Generic name | Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen) |
| Applicant | Abbott Laboratories, Inc. |
| Product code | LOM |
| Received date | Nov 9, 2021 |
| Decision date | Dec 6, 2021 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: